Prime Medicine Inc. (PRME)
undefined
undefined%
At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - - - 5.21M -
Cost of Revenue 147.91M - - - 2.76M
Gross Profit -147.91M - - - -2.76M
Operating Income -191.29M -116.54M -84.47M -932.00K -2.17M
Interest Income - - - - -
Pretax Income -198.41M -122.77M -165.85M -1.54M -2.52M
Net Income -198.13M -121.82M -165.37M -3.41M -2.53M
Selling & General & Admin 38.73M 29.82M 13.92M 3.16M 1.25M
Research & Development 147.91M 86.72M 70.55M 2.98M 920.00K
Other Expenses - 1.90M -80.99M -11.48M -
Operating Expenses 186.64M 116.54M 84.47M 6.14M 2.17M
Interest Expense - 12.13M - - -
Selling & Marketing Expenses -4.65M - - - 1.25M
Cost & Expenses 191.29M 116.54M 84.47M 6.14M 2.17M
Income Tax -279.00K -948.00K -486.00K 1.87M 4.00K
Shares Outstanding (Basic) 90.97M 97.21M 64.90M 71.80M 95.73M
Shares Outstanding (Diluted) 90.97M 97.21M 64.90M 71.80M 95.73M
EPS (Basic) -2.18 -1.25 -2.55 -0.07 -0.03
EPS (Diluted) -2.18 -1.25 -2.55 -0.07 -0.03
EBITDA -193.76M -110.75M -160.99M -889.00K -2.17M
Depreciation & Amortization 4.65M 12.01M 4.86M 43.00K 6.52M